Menu

Biodesix, Inc. BDSX

Full chart Compare
Set alert

Price alert · BDSX

All alert types
8.53 USD -11.31 (-57.01%)

At closeNov 6, 2026, 7:55 PM EST

9.00 +0.47 +5.51%

After hours · Nov 6, 7:55 PM ET

7.99 Day range 13.03
5.46 52-week range 30.60
YTD
+25.44%
1 year
+9.50%

Revenue & Expenses

Other Income → Expenses: $324.00KExpenses → Selling, General & Admin: $87.55MExpenses → Research & Development: $12.00MExpenses → Other Operating Expenses: $107.00KExpenses → Interest Expense: $7.72MGross Profit → Expenses: $71.78MRevenue → Gross Profit: $71.78MRevenue → Cost of Revenue: $16.72MNet Loss → Expenses: $35.27MOther Income$324.00KGross Profit$71.78MNet Loss$35.27MCost of Revenue$16.72MExpenses$107.37MSelling, General & Admin$87.55MResearch & Development$12.00MOther Operating Expenses$107.00KInterest Expense$7.72MRevenue$88.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BDSX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.50M71.32M49.09M38.21M54.51M
71.78M55.75M36.08M24.06M23.99M
-27.87M-34.50M-41.34M-50.59M-39.32M
-35.27M-42.93M-52.15M-65.45M-43.16M
-4.67-6.64-12.80-31.00-31.60
BDSX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
18.99M26.25M26.28M43.09M32.71M
87.48M97.24M99.10M92.91M76.10M
89.94M76.37M94.52M72.30M56.37M
72.85M61.98M60.69M31.85M10.01M
-2.46M20.88M4.58M20.61M19.73M
BDSX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-23.27M-48.65M-22.87M-44.97M-28.22M
-403.00K-3.44M-23.06M-3.53M-2.55M
16.42M52.05M29.13M58.88M1.26M
-403.00K-3.44M-23.06M-3.53M-2.55M
-7.26M-39.00K-16.80M10.38M-29.51M